Judy Hejingdao Wu
Chief Operating Officer bij ASCLETIS PHARMA INC.
Vermogen: 14 M $ op 30-04-2024
Profiel
Judy Hejingdao Wu is currently working as a Director at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd., as a Senior VP-Operations & Executive Director at Ascletis Pharma, Inc., as a Director & Vice President at Ascletis BioScience Co., Ltd., and as a Manager at Gannex LLC.
Previously, she worked as a Vice President at Ascletis Pharmaceuticals Co., Ltd.
Ms. Wu completed her undergraduate degree from Zhejiang University in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASCLETIS PHARMA, INC.
8.18% | 05-03-2024 | 82 827 414 ( 8.18% ) | 14 M $ | 30-04-2024 |
Actieve functies van Judy Hejingdao Wu
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCLETIS PHARMA INC. | Chief Operating Officer | - |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Director/Board Member | - |
| Ascletis BioScience Co., Ltd. | Director/Board Member | 01-01-2014 |
| Gannex LLC | Corporate Officer/Principal | 01-01-2021 |
Eerdere bekende functies van Judy Hejingdao Wu
| Bedrijven | Functie | Einde |
|---|---|---|
| Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal | 01-12-2021 |
Opleiding van Judy Hejingdao Wu
| Zhejiang University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ASCLETIS PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Ascletis BioScience Co., Ltd. | |
| Gannex LLC | |
| Ascletis Pharmaceuticals Co., Ltd. |
